3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Virilism: new trials by email Literature Review of Virilism trials Research Report on Virilism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth FOL-005, Placebo - Hypertrichosis, Alopecia | Phase 1 / Phase 2 | Completed | Follicum AB | 44 | 2016-01-01 | 2017-08-01 |
| Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA), Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA) - Prostate Cancer, Hirsutism | Phase 1 | Completed | Sandoz | 36 | 2006-08-01 | 2017-03-28 |
| Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA), Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA) - Prostate Cancer, Hirsutism | Phase 1 | Completed | Sandoz | 36 | 2006-06-01 | 2017-03-28 |
Hirsutism (3) · Prostatic Neoplasms (2) · Alopecia (1) · Hypertrichosis (1)
Hair Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
bicalutamide (2)
Sandoz (2) · Follicum AB (1)
Germany (1)
Richard Larouche, M.D. (2) · Ulrike Blume-Peytavi, Professor (1)